RFK Jr. Terminates COVID-19 Emergency Declarations, Ending Liability Shields for Vaccine Makers by Mid-2027

Health and Human Services Secretary Robert F. Kennedy Jr. has formally terminated the emergency use authorization declarations for COVID-19 drugs, biological products, and medical devices, citing that the circumstances justifying them no longer exist. The move, announced June 30, 2026, ends broad liability protections under the PREP Act that shielded manufacturers, administrators, and distributors from lawsuits related to these products.

According to the official HHS notice, the declarations for vaccines and drugs will terminate effective June 29, 2027, providing a 12-month transition period, while those for medical devices like tests will end after 180 days on December 26, 2026. This follows the revocation of emergency authorizations for COVID-19 vaccines in 2025 and transitions oversight to standard regulatory pathways.

The termination directly impacts liability shields, opening the door for potential civil lawsuits against vaccine makers for alleged injuries once the protections lapse. Previously extended through 2029 under the prior administration, these measures were justified by ongoing preparedness needs despite the end of the public health emergency in 2023. Kennedy emphasized transparency and accountability, stating emergency authorities should be temporary.

This development aligns with broader scrutiny of vaccine injury compensation programs and could influence personal health decisions by increasing perceived manufacturer accountability, potentially affecting uptake, insurance dynamics, and compensation claims within the transition window.